GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » ROE % Adjusted to Book Value

Minapharm Pharmaceuticals (CAI:MIPH) ROE % Adjusted to Book Value : 21.13% (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals ROE % Adjusted to Book Value?

Minapharm Pharmaceuticals's ROE % for the quarter that ended in Sep. 2024 was 9.51%. Minapharm Pharmaceuticals's PB Ratio for the quarter that ended in Sep. 2024 was 0.45. Minapharm Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 21.13%.


Minapharm Pharmaceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for Minapharm Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals ROE % Adjusted to Book Value Chart

Minapharm Pharmaceuticals Annual Data
Trend Dec22 Dec23
ROE % Adjusted to Book Value
33.40 -1.28

Minapharm Pharmaceuticals Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - -26.23 -18.47 21.13

Competitive Comparison of Minapharm Pharmaceuticals's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Minapharm Pharmaceuticals's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's ROE % Adjusted to Book Value falls into.


;
;

Minapharm Pharmaceuticals ROE % Adjusted to Book Value Calculation

Minapharm Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-1.00% / 0.78
=-1.28%

Minapharm Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.51% / 0.45
=21.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Minapharm Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Minapharm Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY
Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines